<DOC>
	<DOCNO>NCT00625131</DOCNO>
	<brief_summary>This study seek evaluate relationship PTSD , abstinence , factor associate relapse context randomize , clinical smoking cessation trial .</brief_summary>
	<brief_title>Nicotine Patch Pretreatment Smoking Cessation PTSD</brief_title>
	<detailed_description>Smokers PTSD randomly assign 1 2 pre-cessation patch therapy condition ( active patch versus placebo patch ) three week target quit-smoking date . All participant receive bupropion begin 1 week prior quit day , give medically eligible prescribed bupropion . All participant receive two session brief cognitive-behavioral therapy ( CBT ) session begin standard nicotine replacement therapy ( NRT ) quit day . PTSD symptom , mood , smoke crave carefully evaluate throughout study use electronic diary assessment personal digital assistant ( PDA ) . Specifically , participant carefully monitor symptom , mood , craving , use cigarette use electronic diary one week prior pre-cessation period , 3-week pre-cessation treatment period , 6 week post quit date . Since previous study examine factor associate smoke abstinence follow treatment among PTSD smokers10 , predictor treatment response examine . The study design address follow item : Specific Aim 1 : To evaluate whether supplemental nicotine administration ( i.e. , pre-cessation treatment nicotine patch bupropion ) result improve quit rate among smoker PTSD . Hypothesis 1.1 Supplemental nicotine administration pre-cessation period result improve quit rate first quit week placebo patch condition . Specific Aim 2 : To utilize electronic diary assessment PTSD symptom , mood , smoke craving , smoke baseline , pretreatment , quit period evaluate potential mechanism pretreatment nicotine patch may increase abstinence rate . Hypothesis 2.1 Supplemental nicotine administration decrease crave cigarette 2 week pretreatment period compare placebo patch condition . Hypothesis 2.2 Supplemental nicotine administration decrease perceive improvement mood PTSD symptom associate smoke behavior , i.e. , symptom relief ad lib smoking cigarette reduce supplemental nicotine administration compare placebo patch condition . Specific Aim 3 : To investigate potential predictor smoke abstinence relapse associate individual difference affective style include anxiety sensitivity , measure distress tolerance , self-efficacy . Hypothesis 3.1 Increased anxiety sensitivity predictive short abstinence smoking . Hypothesis 3.2 Decreased distress tolerance predictive shorter abstinence . Hypothesis 3.3 Lower self-efficacy smoking abstinence predictive short abstinence . Hypothesis 3.4 Increased PTSD symptom severity negative affect follow quit date associate short abstinence .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Smokers smoke 10 cigarette per day past year ; 1880 year old ; English speaker ; medically stable ; stable current medication regimen Pregnant woman exclude ; participant organic mental disorder , schizophrenia , bipolar disorder , lifetime current PTSD , current substance abuse dependence ; medical condition contraindicate nicotine replacement therapy ; use form nicotine ( cigar , nicotine gum , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Stress Disorders , Posttraumatic</keyword>
	<keyword>Tobacco Use Disorder</keyword>
</DOC>